ADVERTISEMENT

COVID-19: waning protection against infection warrants boosters

Liz Scherer   |   Clinical Summary   |   10 June 2022
ADVERTISEMENT

Takeaway

  • SARS-CoV-2 mRNA-1273, BNT162b2, and Ad26.COV2.S vaccine effectiveness (VE) are associated with waning temporal protection against infection and symptomatic COVID-19, but VE against severe disease is preserved in most circumstances.

Why this matters

  • Target booster doses first to patients of age ≥65 years,...

          

Topic Challenges

left
right